Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Search Results for: clinical trials

Can Surrogate Markers Speed Up Clinical Trials in CLL?

Both progression free survival (PFS) and measurable (minimal) residual disease (MRD) status were found to strongly correlate with overall survival (OS), suggesting these markers could be safely used as surrogates for OS and thus provide quicker results in clinical trials.

Clinical Trials Concerning COVID-19 Only

Research & Clinical Trials Concerning COVID-19 Only All the advancements in preventing and treating COVID-19 are due to the brave volunteers who entered clinical trials for vaccines, monoclonal antibodies for both

Didn't find what you where looking for?

Try our advanced search page!